{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:35:44Z","timestamp":1788244544747,"version":"build-2803163510"},"reference-count":45,"publisher":"Impact Journals, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2021,2,15]]},"DOI":"10.18632\/aging.202380","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T15:24:48Z","timestamp":1611329088000},"page":"4138-4156","source":"Crossref","is-referenced-by-count":28,"title":["Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma"],"prefix":"10.18632","volume":"13","author":[{"given":"Pengfei","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Henan 450052, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450052, Henan, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Henan 450052, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Henan 450052, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Henan 450052, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Henan 450052, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunlun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Henan 450052, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management.","volume":"1","author":"Roberts","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma.","volume":"38","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"a021535","DOI":"10.1101\/cshperspect.a021535","article-title":"Treatment of liver cancer.","volume":"5","author":"Chen","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/hep.23485","article-title":"A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma.","volume":"5","author":"Camm\u00e0","year":"2010","journal-title":"Hepatology"},{"key":"5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1042\/0264-6021:3510067","article-title":"Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.","volume":"35","author":"Ratnam","year":"2000","journal-title":"Biochem J"},{"key":"6","doi-asserted-by":"publisher","first-page":"638","DOI":"10.4161\/cbt.20081","article-title":"Increased aldehyde reductase expression mediates acquired radioresistance of laryngeal cancer cells via modulating p53.","volume":"1","author":"Hwang","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"7","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1084\/jem.20160903","article-title":"AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program.","volume":"21","author":"Dong","year":"2017","journal-title":"J Exp Med"},{"key":"8","doi-asserted-by":"publisher","first-page":"33694","DOI":"10.18632\/oncotarget.16624","article-title":"AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling.","volume":"8","author":"Liao","year":"2017","journal-title":"Oncotarget"},{"key":"9","doi-asserted-by":"publisher","first-page":"676","DOI":"10.7150\/thno.21463","article-title":"AKR1C1 activates STAT3 to promote the metastasis of non-small cell lung cancer.","volume":"8","author":"Yang","year":"2018","journal-title":"Theranostics"},{"key":"10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mce.2018.07.002","article-title":"AKR1C3 (type 5 17\u03b2-hydroxysteroid dehydrogenase\/prostaglandin F synthase): roles in Malignancy and endocrine disorders.","volume":"48","author":"Penning","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jsbmb.2010.12.013","article-title":"17\u03b2-hydroxysteroid dehydrogenases (17\u03b2-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development.","volume":"12","author":"Adamski","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"12","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1021\/bi036046x","article-title":"Crystal structure of human prostaglandin F synthase (AKR1C3).","volume":"4","author":"Takusagawa","year":"2004","journal-title":"Biochemistry"},{"key":"13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jsbmb.2015.09.037","article-title":"Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells.","volume":"15","author":"Campbell","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.metabol.2019.153947","article-title":"AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease.","volume":"9","author":"Marschall","year":"2019","journal-title":"Metabolism"},{"key":"15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jsbmb.2019.02.002","article-title":"AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells.","volume":"18","author":"Tomlinson","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gutjnl-2019-318506","article-title":"CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma.","volume":"6","author":"Bernards","year":"2020","journal-title":"Gut"},{"key":"17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma.","volume":"1","author":"Finn","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ar.21531","article-title":"Multivariate analysis of several molecular markers and clinicopathological features in postoperative prognosis of hepatocellular carcinoma.","volume":"29","author":"Liao","year":"2012","journal-title":"Anat Rec (Hoboken)"},{"key":"19","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1210\/en.2002-0032","article-title":"Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.","volume":"14","author":"Penning","year":"2003","journal-title":"Endocrinology"},{"key":"20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev.pharmtox.47.120505.105337","article-title":"Aldo-keto reductases and bioactivation\/detoxication.","volume":"4","author":"Penning","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"21","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1080\/13543776.2017.1379503","article-title":"Aldo-keto reductase (AKR) 1C3 inhibitors: a patent review.","volume":"2","author":"Penning","year":"2017","journal-title":"Expert Opin Ther Pat"},{"key":"22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/jcp.2007.050906","article-title":"Expression of androgen receptor through androgen-converting enzymes is associated with biological aggressiveness in prostate cancer.","volume":"6","author":"Naito","year":"2008","journal-title":"J Clin Pathol"},{"key":"23","doi-asserted-by":"publisher","first-page":"11471","DOI":"10.1158\/0008-5472.CAN-06-1448","article-title":"17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.","volume":"6","author":"St\u00e5l","year":"2006","journal-title":"Cancer Res"},{"key":"24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.tem.2004.09.004","article-title":"The backdoor pathway to dihydrotestosterone.","volume":"1","author":"Auchus","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"25","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.steroids.2012.03.015","article-title":"Steroid biosynthesis and prostate cancer.","volume":"7","author":"Auchus","year":"2012","journal-title":"Steroids"},{"key":"26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nrendo.2011.122","article-title":"The G-protein-coupled estrogen receptor GPER in health and disease.","volume":"7","author":"Barton","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2018.07.005","article-title":"AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling.","volume":"3","author":"Wu","year":"2018","journal-title":"Urol Oncol"},{"key":"28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.steroids.2014.01.013","article-title":"5\u03b2-reduced steroids and human \u0394(4)-3-ketosteroid 5\u03b2-reductase (AKR1D1).","volume":"8","author":"Penning","year":"2014","journal-title":"Steroids"},{"key":"29","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.steroids.2011.01.003","article-title":"Substrate specificity and inhibitor analyses of human steroid 5\u03b2-reductase (AKR1D1).","volume":"7","author":"Penning","year":"2011","journal-title":"Steroids"},{"key":"30","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1210\/jc.2003-030596","article-title":"Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol\/cortisone metabolite ratios in men with fatty liver.","volume":"8","author":"Walker","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.steroids.2007.12.001","article-title":"Human Delta4-3-oxosteroid 5beta-reductase (AKR1D1) deficiency and steroid metabolism.","volume":"7","author":"Shackleton","year":"2008","journal-title":"Steroids"},{"key":"32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/ncb1676","article-title":"ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation.","volume":"1","author":"Lee","year":"2008","journal-title":"Nat Cell Biol"},{"key":"33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","article-title":"ERK1\/2 MAP kinases: structure, function, and regulation.","volume":"6","author":"Roskoski","year":"2012","journal-title":"Pharmacol Res"},{"key":"34","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.trecan.2018.07.002","article-title":"Protein-protein interactions: emerging oncotargets in the RAS-ERK pathway.","volume":"4","author":"Crespo","year":"2018","journal-title":"Trends Cancer"},{"key":"35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jhep.2007.08.018","article-title":"Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection.","volume":"4","author":"Baba","year":"2008","journal-title":"J Hepatol"},{"key":"36","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000315247","article-title":"Gender disparity of hepatocellular carcinoma: the roles of sex hormones.","volume":"7","author":"Chen","year":"2010","journal-title":"Oncology"},{"key":"37","doi-asserted-by":"publisher","first-page":"R165","DOI":"10.1530\/ERC-13-0283","article-title":"Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.","volume":"2","author":"Chang","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"38","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/jgh.12934","article-title":"Gender disparity in chronic hepatitis B: mechanisms of sex hormones.","volume":"3","author":"Yeh","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molonc.2012.06.005","article-title":"Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion.","volume":"6","author":"Li","year":"2012","journal-title":"Mol Oncol"},{"key":"40","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1053\/j.gastro.2008.05.046","article-title":"Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma.","volume":"13","author":"Chang","year":"2008","journal-title":"Gastroenterology"},{"key":"41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/nmo.12015","article-title":"Nestin-expressing cells in the gut give rise to enteric neurons and glial cells.","volume":"2","author":"Goldstein","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data.","volume":"2","author":"Smyth","year":"2010","journal-title":"Bioinformatics"},{"key":"43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"Affy\u2014analysis of affymetrix GeneChip data at the probe level.","volume":"2","author":"Irizarry","year":"2004","journal-title":"Bioinformatics"},{"key":"44","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.","volume":"6","author":"Schultz","year":"2013","journal-title":"Sci Signal"},{"key":"45","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.biomaterials.2014.10.016","article-title":"CPNE7, a preameloblast-derived factor, regulates odontoblastic differentiation of mesenchymal stem cells.","volume":"3","author":"Park","year":"2015","journal-title":"Biomaterials"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T16:13:41Z","timestamp":1617725621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,2,15]]}},"alternative-id":["202380","33493134"],"URL":"https:\/\/doi.org\/10.18632\/aging.202380","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]}}}